Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.50 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20739453 | 0.86 | LMNA (0.53) | POLBPSMB1PSMB5PSMB2CYP3A4 | |
| SCHEMBL3624111 | 0.85 | LMNA (0.51) | POLBPSMB1PSMB5PSMB2CYP3A4 | |
| SCHEMBL7912663 | 0.79 | PSMB1 (0.48) | POLBPSMB1PSMB5PSMB2CYP2D6 | |
| SCHEMBL123415 | 0.78 | MAPT (0.55) | POLBTSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL26302359 | 0.78 | ESR1 (0.54) | POLBPSMB1PSMB5PSMB2ESR1 | |
| SCHEMBL14173383 | 0.77 | PSMB1 (0.49) | POLBPSMB1PSMB5PSMB2CYP2D6 | |
| SCHEMBL13385077 | 0.77 | ALDH1A1 (0.47) | POLBPSMB1PSMB5PSMB2CYP3A4 | |
| SCHEMBL6345254 | 0.76 | TSHR (0.62) | PSMB1PSMB5PSMB2CYP2D6ESR1 | |
| SCHEMBL12517096 | 0.76 | PSMB1 (0.48) | POLBPSMB1PSMB5PSMB2CYP2D6 | |
| SCHEMBL13385083 | 0.76 | ALDH1A1 (0.46) | PSMB1PSMB5PSMB2CYP3A4ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10654965-B2 | Method of producing five-carbon ring-containing compound and five-carbon ring derivative-containing polyurethane, and five-carbon ring derivative-containing polyurethane | NATIONAL CHUNG SHAN INSTITUTE OF SCIENCE AND TECHNOLOGY (TW) | 2020-05-19 | — | — | US | disclosed |
| US-20190048123-A1 | METHOD OF PRODUCING FIVE-CARBON RING-CONTAINING COMPOUND AND FIVE-CARBON RING DERIVATIVE-CONTAINING POLYURETHANE, AND FIVE-CARBON RING DERIVATIVE-CONTAINING POLYURETHANE | NATIONAL CHUNG SHAN INSTITUTE OF SCIENCE AND TECHNOLOGY (TW) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190048123-A1 | METHOD OF PRODUCING FIVE-CARBON RING-CONTAINING COMPOUND AND FIVE-CARBON RING DERIVATIVE-CONTAINING POLYURETHANE, AND FIVE-CARBON RING DERIVATIVE-CONTAINING POLYURETHANE | UROD, DCUN1D5, DCTD | POLB 1327/4885PSMB1 3034/4885PSMB5 580/4885 |
| US-10654965-B2 | Method of producing five-carbon ring-containing compound and five-carbon ring derivative-containing polyurethane, and five-carbon ring derivative-containing polyurethane | UROD, DCUN1D5, DCTD | POLB 1327/4885PSMB1 3034/4885PSMB5 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.